BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12549939)

  • 1. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
    Qu Q; Russell PL; Sharom FJ
    Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter.
    Liu R; Sharom FJ
    Biochemistry; 1997 Mar; 36(10):2836-43. PubMed ID: 9062112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
    Liu R; Sharom FJ
    Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.
    Russell PL; Sharom FJ
    Biochem J; 2006 Oct; 399(2):315-23. PubMed ID: 16803457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the nucleotide binding properties of SV40 T antigen using fluorescent 3'(2')-O-(2,4,6-trinitrophenyl)adenine nucleotide analogues.
    Huang SG; Weisshart K; Fanning E
    Biochemistry; 1998 Nov; 37(44):15336-44. PubMed ID: 9799494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
    Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
    Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition state P-glycoprotein binds drugs and modulators with unchanged affinity, suggesting a concerted transport mechanism.
    Qu Q; Chu JW; Sharom FJ
    Biochemistry; 2003 Feb; 42(5):1345-53. PubMed ID: 12564938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The second step of ATP binding to DnaK induces peptide release.
    Theyssen H; Schuster HP; Packschies L; Bukau B; Reinstein J
    J Mol Biol; 1996 Nov; 263(5):657-70. PubMed ID: 8947566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic mechanism of P-glycoprotein.
    Senior AE
    Acta Physiol Scand Suppl; 1998 Aug; 643():213-8. PubMed ID: 9789563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
    Rao US
    Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites.
    Senior AE; Bhagat S
    Biochemistry; 1998 Jan; 37(3):831-6. PubMed ID: 9454572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway.
    Tombline G; Muharemagić A; White LB; Senior AE
    Biochemistry; 2005 Sep; 44(38):12879-86. PubMed ID: 16171403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 1999 May; 38(21):6887-96. PubMed ID: 10346910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2005 Aug; 44(30):10250-8. PubMed ID: 16042402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P glycoprotein and the mechanism of multidrug resistance.
    Váradi A; Szakács G; Bakos E; Sarkadi B
    Novartis Found Symp; 2002; 243():54-65; discussion 65-8, 180-5. PubMed ID: 11990782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation bypasses the requirement for ATP hydrolysis in regenerating low affinity transition state conformation of human P-glycoprotein.
    Maki N; Moitra K; Ghosh P; Dey S
    J Biol Chem; 2006 Apr; 281(16):10769-77. PubMed ID: 16505485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
    Tombline G; Donnelly DJ; Holt JJ; You Y; Ye M; Gannon MK; Nygren CL; Detty MR
    Biochemistry; 2006 Jul; 45(26):8034-47. PubMed ID: 16800628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis.
    Sauna ZE; Smith MM; Muller M; Ambudkar SV
    J Biol Chem; 2001 Jun; 276(24):21199-208. PubMed ID: 11287418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
    Qu Q; Sharom FJ
    Biochemistry; 2001 Feb; 40(5):1413-22. PubMed ID: 11170469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.